Pharma giant strikes deal to save breast cancer drug funding

By Nick Renaud-Komiya2015-03-17T12:46:00

Source: Breast cancer radiology

The Swiss drug giant Novartis has struck a deal with NHS England to prevent one of its breast cancer treatments being axed from the cancer drugs fund.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters
10 expert briefings every fortnight (Premium only)
Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

to HSJ

Already a subscriber? Sign into your account here